1-Glycerol monostearate

Product Information

Molecular Formula:
C21H42O4
Molecular Weight:
358.56
Description
Glyceryl Monostearate is used as an emulsifier.
Additive in health care products.
Synonyms
Monostearin; 1-Stearoyl-rac-glycerol; Glyceryl stearate; Glyceryl Monostearate; 1-Glyceryl stearate; 1-Monooctadecanoyl-rac-glycerol; 1-Monostearin; 1-Monostearoylglycerol; 1-Monostearoyl-rac-glycerol
IUPAC Name
2,3-dihydroxypropyl octadecanoate
Canonical SMILES
CCCCCCCCCCCCCCCCCC(=O)OCC(CO)O
InChI
InChI=1S/C21H42O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(24)25-19-20(23)18-22/h20,22-23H,2-19H2,1H3
InChI Key
VBICKXHEKHSIBG-UHFFFAOYSA-N
Boiling Point
476.9±25.0°C (Predicted)
Melting Point
57-59°C
Purity
>60.0%(GC)
Density
0.9678 g/cm3
Solubility
Soluble in Hot Ethanol, Ether, Chloroform
Appearance
White to Off-White Solid
Application
Ingredient of health care products.
Storage
Store at RT

Computed Properties

XLogP3
7.4
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
20
Exact Mass
358.30830982 g/mol
Monoisotopic Mass
358.30830982 g/mol
Topological Polar Surface Area
66.8Ų
Heavy Atom Count
25
Formal Charge
0
Complexity
281
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
1
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes

Patents

Publication Number Title Priority Date
US-2021186922-A1 Methods and compositions for reducing epigenetic age and mitochondrial dysfunction 2021-02-16
EP-3818972-A2 Piroctone olamine granules for use in cosmetic compositions 2021-01-29
US-11028172-B1 Anti-TIGIT antibodies and uses thereof 2020-11-10
US-2021007978-A1 Fixed Dose Oral Testosterone Undecanoate Compositions and Use Thereof 2020-09-25
US-11033516-B1 Combination therapies with disulfiram 2020-09-18
US-11028174-B1 Bifunctional molecules targeting PD-L1 and TGF-β 2020-07-28
US-11020349-B1 Transmucosal dosage forms of remdesivir 2020-07-14
US-10882852-B1 3-vinylquinolines as cancer cells inhibitors 2020-07-09
US-10981996-B1 Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use 2020-06-01
US-10981997-B1 Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use 2020-06-01

Literatures

PMID Publication Date Title Journal
29968805 2018-07-03 Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics Scientific reports
22487877 2012-10-01 Influence of the presence of monoglyceride on the interfacial properties of soy protein isolate Journal of the science of food and agriculture
22677417 2012-09-15 Improved physical stability and injectability of non-aqueous in situ PLGA microparticle forming emulsions International journal of pharmaceutics
22385296 2012-09-01 Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma Journal of liposome research
22797534 2012-08-10 Lipid nanoparticles based on butyl-methoxydibenzoylmethane: in vitro UVA blocking effect Nanotechnology
22531854 2012-07-15 Preparation and evaluation of granules with pH-dependent release by melt granulation International journal of pharmaceutics
22486965 2012-07-01 Characterization of agglomerated carvedilol by hot-melt processes in a fluid bed and high shear granulator International journal of pharmaceutics
23112531 2012-07-01 Preparation and evaluation of montelukast sodium loaded solid lipid nanoparticles Journal of young pharmacists : JYP
22405986 2012-05-30 A novel mathematical model considering change of diffusion coefficient for predicting dissolution behavior of acetaminophen from wax matrix dosage form International journal of pharmaceutics
22812010 2012-05-01 [Micromeritic evaluation of the direct compression excipient LubriTose AN] Yao xue xue bao = Acta pharmaceutica Sinica
The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Online Inquiry
  • Verification code
USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2024 BOC Sciences. All rights reserved.
Inquiry Basket